Cell-free protein synthesis (CFPS) eliminates the need to maintain living cells and allows greater control of reaction conditions than in vivo expression systems but is limited by its sensitivity to ...
CEVEC Pharmaceuticals entered into an agreement with UCB covering the evaluation and use of CEVEC’s proprietary ELEVECTA ® technology for the R&D and manufacturing of Adeno-Associated Virus (AAV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback